Moomoo AI 已提取核心信息
180 Life Sciences Corp. has reported the exercise of pre-funded warrants on March 6 and 7, 2024, resulting in the issuance of 72,000 and 62,000 shares of common stock, respectively. This follows the company's 1-for-19 reverse stock split effective on February 28, 2024. The transactions, which involved an aggregate cash amount of $254.60, were exempt from registration under Section 4(a)(2) of the Securities Act of 1933. Following these exercises, the company announced that no pre-funded warrants remain outstanding and the total issued and outstanding common stock amounts to approximately 852,758 shares. The resale of the shares was registered under a registration statement declared effective under the Securities Act. The information was disclosed in a Form 8-K filed with the SEC, signed by CEO James N. Woody, M.D., Ph.D., on March 8, 2024.
180 Life Sciences Corp. has reported the exercise of pre-funded warrants on March 6 and 7, 2024, resulting in the issuance of 72,000 and 62,000 shares of common stock, respectively. This follows the company's 1-for-19 reverse stock split effective on February 28, 2024. The transactions, which involved an aggregate cash amount of $254.60, were exempt from registration under Section 4(a)(2) of the Securities Act of 1933. Following these exercises, the company announced that no pre-funded warrants remain outstanding and the total issued and outstanding common stock amounts to approximately 852,758 shares. The resale of the shares was registered under a registration statement declared effective under the Securities Act. The information was disclosed in a Form 8-K filed with the SEC, signed by CEO James N. Woody, M.D., Ph.D., on March 8, 2024.
180 Life Sciences Corp. 报告称，2024年3月6日和7日行使了预先注资的认股权证，分别发行了72,000股和62,000股普通股。在此之前，该公司于2024年2月28日生效了19比19的反向股票拆分。根据1933年《证券法》第4（a）（2）条，这些交易涉及的现金总额为254.60美元，无需注册。在这些活动之后，该公司宣布没有未偿还的预先注资认股权证，已发行和流通的普通股总额约为852,758股。股票的转售是根据一份根据《证券法》宣布生效的注册声明进行登记的。该信息在向美国证券交易委员会提交的8-K表格中披露，该表格由首席执行官詹姆斯·伍迪医学博士、博士于2024年3月8日签署。
180 Life Sciences Corp. 报告称，2024年3月6日和7日行使了预先注资的认股权证，分别发行了72,000股和62,000股普通股。在此之前，该公司于2024年2月28日生效了19比19的反向股票拆分。根据1933年《证券法》第4（a）（2）条，这些交易涉及的现金总额为254.60美元，无需注册。在这些活动之后，该公司宣布没有未偿还的预先注资认股权证，已发行和流通的普通股总额约为852,758股。股票的转售是根据一份根据《证券法》宣布生效的注册声明进行登记的。该信息在向美国证券交易委员会提交的8-K表格中披露，该表格由首席执行官詹姆斯·伍迪医学博士、博士于2024年3月8日签署。
有用
没用
